BRAXLA

Fusion proteins for treatment of viral diseases and cancer; pharmaceutical preparations for use in the treatment of infectious diseases, viral diseases, cancer, immune disorders, autoimmune diseases, blood disorders, central nervous system disorders, immunologic conditions, neurological disorders, oncological conditions, AIDS-Related Kaposi's Sarcoma and inflammation